• Amgen SVP and chief compliance officer Nancy A. Grygiel exercised stock options on Aug. 6, 2026, acquiring 2,970 common shares at USD 177.46 and USD 177.31.
• She sold 2,970 shares the same day at USD 402.16, leaving 7,340 shares directly owned.
• The filing also reports 106 shares held indirectly through a 401(k) plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amgen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000318154-26-000129), on August 07, 2026, and is solely responsible for the information contained therein.